<DOC>
	<DOCNO>NCT01644747</DOCNO>
	<brief_summary>The aim investigate effect transcranial Direct Current Stimulation ( tDCS ) apply anodal left CDLPF patient resistant depression compare patient treat conventional therapy . The tDCS use add-on drug treatment resistant depression stabilize 4 week ( antidepressant SSRIs ( Selective Serotonin Reuptake Inhibitors ) SNRIs ( Serotonine-Norepinephrine Reuptake Inhibitors ) unipolar patient lithium bipolar patient ) . The delay 4 week minimum observe non-response . Moreover , term ethical point view , 's difficult wait 6 8 week observe non-response treatment . This randomized 2-arm parallel , double blind study compare 2 group 60 patient ( 48 unipolar plus 12 bipolar patient per group . Patients select psychiatric department University Hospital different center two group match age ( +/- 5 year ) , gender depression diagnosis ( unipolar v bipolar ) . After give informed consent , patient evaluate psychiatrist use Hamilton Depression Rating Scale ( HDRS ) , Montgomery Asberg Depression Rating Scale ( MADRS ) , STAI Beck Depression Inventory ( BDI ) bipolar patient , Young Mania Rating Scale ( YMRS ) . The complete assessment take 50 minute . A neuropsychologist assessment also realize 20 minute use Crossing Test ( COT ) , Trail Making Test ( TMT ) , Isaacs Set Test ( IST ) Cardebat fluency Task . After locate leave DLPFC , treatment active tDCS current 2 mA sham direct 30-minute session . A psychometric assessment conduct end treatment week 4 , 12 finally 24 week stop treatment . The neuropsychologist assessment conduct 4 week end treatment . Scales comfort acceptability also propose patient determine whether gene cause treatment . These people recruit voluntary basis , notification consent 6 research center . This study conduct period 36 month . This study support grant French Hospital Program Clinical Reseach ( PHRC N/2011-60-2011-A01074-37 )</brief_summary>
	<brief_title>tDCS add-on Treatment Resistant Major Depression Uni- Bipolar Patients</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<criteria>subject whose MDD single recurrent without psychotic feature accord DSMIVTR subject diagnosis resistant major depression ( ≥1 fail antidepressant treatment current depressive episode ) HDRS21 score ≥ 21 drug treatment SSRIs SNRIs unipolar patient Lithium bipolar patient least 4 week righthanded patient without severe progressive somatic pathology ( especially tumor disease , degenerative disease ) without severe cognitive impairment make psychometric evaluation impossible except antidepressant Lithium treatment , psychotropic follow tolerated course study : hydroxyzin ; cyamemazin ( 100 mg/day ) ; hypnotic ( imidazopyridin ) . subject treat antipsychotic mood stabilizer anticonvulsant ECT rTMS current depressive episode subject resistant SSRIs SNRIs unipolar patient Lithium bipolar patient subject mixed feature pregnancy and/or lactation presence specific contraindication tDCS ( e.g. , personal history epilepsy , metallic head implant , cardiac pacemaker )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Resistant Depression</keyword>
	<keyword>Moods disorder</keyword>
	<keyword>Unipolar depression</keyword>
	<keyword>Bipolar disorder</keyword>
	<keyword>tDCS</keyword>
</DOC>